Sulfanilamide: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Sulfanilamide}} | |||
'''''For patient information, click <u>[[Sulfanilamide (patient information)|here]]'''''</u>. | |||
| | |||
{{CMG}}; {{AE}} {{MM}} | |||
==Overview== | ==Overview== | ||
== | ==Category== | ||
[[Sulfonamide]] | |||
== | ==US Brand Names== | ||
AVC VAGINAL<sup>®</sup> | |||
==FDA Package Insert== | |||
''' [[Sulfanilamide description|Description]]''' | |||
'''| [[Sulfanilamide clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Sulfanilamide microbiology|Microbiology]]''' | |||
'''| [[Sulfanilamide indications and usage|Indications and Usage]]''' | |||
'''| [[Sulfanilamide contraindications|Contraindications]]''' | |||
'''| [[Sulfanilamide warnings and precautions|Warnings and Precautions]]''' | |||
'''| [[Sulfanilamide adverse reactions|Adverse Reactions]]''' | |||
'''| [[Sulfanilamide overdosage|Overdosage]]''' | |||
'''| [[Sulfanilamide dosage and administration|Dosage and Administration]]''' | |||
'''| [[Sulfanilamide how supplied|How Supplied]]''' | |||
'''| [[Sulfanilamide labels and packages|Labels and Packages]]''' | |||
==Mechanism of Action== | |||
==References== | |||
{{Reflist|2}} | |||
{{ | |||
[[Category:Antibiotics]] | |||
[[Category:Wikinfect]] |
Revision as of 08:30, 9 January 2014
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Category
US Brand Names
AVC VAGINAL®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Dosage and Administration | How Supplied | Labels and Packages